CVS Health (CVS) Expected to Announce Quarterly Earnings on Thursday

CVS Health (NYSE:CVS - Get Free Report) is anticipated to release its Q1 2025 earnings data before the market opens on Thursday, May 1st. Analysts expect CVS Health to post earnings of $1.62 per share and revenue of $93.07 billion for the quarter. CVS Health has set its FY 2025 guidance at 5.750-6.000 EPS.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, analysts expect CVS Health to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

CVS Health Stock Performance

Shares of NYSE CVS traded down $0.62 during trading on Friday, reaching $65.30. 5,020,541 shares of the company traded hands, compared to its average volume of 11,841,771. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The firm has a 50 day simple moving average of $66.48 and a 200-day simple moving average of $58.82. CVS Health has a 52-week low of $43.56 and a 52-week high of $71.45. The stock has a market capitalization of $82.33 billion, a PE ratio of 17.84, a P/E/G ratio of 0.98 and a beta of 0.57.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.07%. The ex-dividend date is Tuesday, April 22nd. CVS Health's dividend payout ratio is currently 72.68%.

Analyst Upgrades and Downgrades

CVS has been the topic of several research analyst reports. JPMorgan Chase & Co. increased their price target on CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a report on Tuesday, February 18th. Argus set a $77.00 target price on CVS Health in a research report on Tuesday, February 18th. Piper Sandler upped their price target on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research report on Friday, March 21st. UBS Group lowered their price objective on shares of CVS Health from $62.00 to $59.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 11th. Finally, Robert W. Baird upped their target price on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a report on Tuesday, April 15th. Four analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $71.83.

Insider Buying and Selling

In other CVS Health news, SVP James David Clark sold 7,513 shares of the business's stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares of the company's stock, valued at $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Michael F. Mahoney purchased 30,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the acquisition, the director now directly owns 39,356 shares in the company, valued at $2,625,045.20. This trade represents a 320.65 % increase in their position. The disclosure for this purchase can be found here. 1.22% of the stock is currently owned by company insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.